Several biomarkers are used to identify endothelial cell damage and systemic inflammation, for example, interleukins (IL-6, IL-8, IL-1β), however, the types of inflammatory markers measured from the MED-diet in adults with cancer in this review varied and were often secondary or tertiary outcome measures. The gene discussed is IL1B; the disease is cancer.